share_log

主营产品量价齐升 多家化工企业前三季度业绩预喜

Main products see both volume and price rise, many chemical companies expect good performance in the first three quarters.

Breakings ·  Oct 16 07:12

With the recent continuous release of the 2024 third quarter performance forecasts of A-share companies, listed companies in the chemical industry frequently report positive performance news. According to incomplete statistics from reporters, as of the evening of October 15th, nearly 20 listed companies in the chemical industry have disclosed performance forecasts for the first three quarters of this year. Jiangsu Zhengdan Chemical Industry, Yunnan Yuntianhua, Lianke Technology, and other companies have released the third quarter reports for 2024. Among the companies that have disclosed performance forecasts, over 90% are expected to be profitable (including year-on-year growth, slight growth, etc.), with many companies turning losses into profits year-on-year; nearly 10 companies are expected to have a performance growth rate of over 100% compared to the previous year, with Brother Enterprises Holding expecting a performance growth rate over 10 times year-on-year. It is worth mentioning that in the third quarter report disclosed by Jiangsu Zhengdan Chemical Industry on the evening of the 15th, the single-quarter performance growth rate of the company in the third quarter exceeded 300 times year-on-year. Reporters noted that some listed companies in the chemical industry attribute the main reasons for the growth in performance in the first three quarters to: recovery in the industry's prosperity, increase in the company's comprehensive gross margin, and improvement in the company's profit level. (Securities Times)

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment